Report

src

Global Clinical Trials Matching Software Market Size, Share & COVID-19 Impact Analysis, By Component (Services and Software), By End User (Clinical Research Organizations (CRO), Pharmaceutical and biotechnology Companies, and Medical Device Firms), By Deployment Mode (On-Premise and Web and Cloud-based) and Regional Forecasts, 2022-2028

The global clinical trials matching software market size was valued at USD 152.6 million in 2021. The market is projected to grow from USD 152.6 million in 2021 to USD 326.23 million by 2028, exhibiting a CAGR of 13.50% during the forecast period.
 
The prevalence of chronic illnesses and the growing demand for clinical trials are predicted to fuel the market for clinical trial matching software during the anticipated time frame. Market participants are focusing more on new features and creating innovative products due to supportive government initiatives and swiftly advancing technology. Additionally, the healthcare industry is also growing as a result of the quick rise in the number of businesses offering novel customizable features. Clinical trial software is predicted to grow in importance in the future, driving the global market for clinical trial matching software throughout the forecast period due to the increasing demand for remote monitoring services and digitally connected platforms.
 
COVID-19 IMPACT

The COVID-19 epidemic is a remarkable worldwide public health disaster that has affected most industries, and long-term effects are anticipated to impede industrial growth in the next years. Numerous clinical studies aiming at bringing new therapies to market have been severely hampered by COVID-19, wrecking havoc on international markets. The situation has worsened as a result of labor shortages, supply chain disruptions, and other limitations. Limitations and boundaries have had an impact on a number of ongoing clinical research investigations in many therapy fields. Clinical research teams have developed a new COVID-19 vaccination to combat the problematic condition.
 
DRIVING FACTORS

Growing Clinical Trial Activity is Anticipated to Fuel Market Expansion

It is anticipated that rising clinical trial activity will fuel the market for clinical trials matching software. Over the past few decades, there had been a tremendous increase in clinical studies. This is a result of the increased penetration of cutting-edge medical technology and the rising desire for novel medications with higher efficacy. But because clinical trials are designed to gather and organize data that can be shared with several healthcare practitioners and disseminated across multiple systems, a clinical trial matching system is quick and inexpensive. The monitoring and tracing of patient registrations and databases, as well as location identification and recruitment, can all be aided by this technology.
 
RESTRAINING FACTORS

Market's Expansion is Being Hampered by the High Cost of Matching Software

The high cost of matching systems is constraining the market expansion of clinical trial matching software. Initialization, contractual term commitment, per user, per study, training, support and maintenance, validation/21 part 11 compliance, and system integration fees collectively increase the entire cost necessary for clinical trial matching software solutions deployment. Setup fees apply to both on-premises and SaaS solutions. Companies are assessed additional configuration and modification fees following their unique organizational and research needs. Different cost structures are seen depending on the number of users and sites taken into consideration.
 
SEGMENTATION

By Component


Based on components, the clinical trials matching software market is segmented into services and software. The software category dominated the market in 2021. High utilization and greater medication trial adoption support this segment's growth. Complex medication trials are being encouraged by numerous biotech, pharmaceutical, and clinical research organization corporations.
 
By End-User

By end-user, the market is segmented into clinical research organizations (CRO), pharmaceutical and biotechnology companies, and medical device firms. The pharmaceutical and biotechnology companies category dominated the market in 2021 due to the numerous clinical trials needed for product introductions. The market is divided into pharmaceutical and biotechnology companies, CROs, and medical device companies based on end-use.
 
By Deployment Mode

By deployment mode, the market is segmented into on-premise and web & cloud-based. The web & cloud-based category dominated the market in 2021 due to the cloud computing architecture, which is simpler to run and requires no ongoing maintenance. Development costs are decreased because a company's server infrastructure is not needed. The integration time is much shortened, and it is accessible from anywhere. Data sharing is practical and enables teamwork on many projects.
 
REGIONAL INSIGHTS

 
North America is projected to hold the largest clinical trials matching software market share over the forecast period. The introduction of drug trial matching systems by American pharmaceutical and biotechnology businesses is credited with the growth. Additionally, the encouraging government IT initiatives and the growing use of patient matching and clinical trial matching software are contributing to the expansion of this industry.
 
On the other hand, the Asia Pacific clinical trials matching software market is anticipated to grow significantly over the forecast period due to the region's accessibility to a high number of patients. Many businesses want to locate their research and development operations in Asia Pacific, contributing to the local market expansion. This expansion is explained by an increase in healthcare IT initiatives, a booming economy, and a general improvement in the healthcare infrastructure, particularly in developing nations like China and India.
 
LIST OF KEY COMPANIES PROFILED:
  • Advarra
  • Antidote Technologies, Inc.
  • IBM Clinical Development
  • Clinical Trials Mobile Application
  • SSS International Clinical Research
  • Aris Global
  • Clario
  • Bsi Business Systems Integration AG
  • Microsoft Corporation
  • Ofni Systems
 
KEY INDUSTRY DEVELOPMENTS:
  • July 2022: The Advarra Cloud solution facilitates end-to-end integration and automated, frictionless research document exchange between sites, sponsors, and CROs. It was created in collaboration with Advarra's Site-Sponsor Consortium.
REPORT SCOPE AND SEGMENTATION
 
Attributes Details
Study Period 2016-2028
Base Year 2021
Estimated Year 2022
Forecast Period 2022-2028
Historical Period 2016-2020
Unit Revenue (USD Million) and Volume (Kilo Tons)
Segmentation By Components, By End-User, By Deployment Mode and  By Geography
By Component
  • Services
  • Software
By End User
  • Clinical Research Organizations (CRO)
  • Pharmaceutical and biotechnology Companies
  • Medical Device Firms
By Deployement Mode
  • On-Premise
  • Web and Cloud based
By Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa
Chapter 1    Preface

    1.1    Report Scope and Description
        1.1.1    Study Purpose
        1.1.2    Target Audience
        1.1.3    USP and Key Offerings
    1.2    Key Benefits for Stakeholders
    1.3    Report Scope

Chapter 2    Report Summary

    2.1    Key Findings
        2.1.1    Top Investment Pockets
    2.2    Market Snapshot: Global Clinical Trials Matching Software Market
    2.3    Global Clinical Trials Matching Software Market, 2018 – 2028 (US$ Mn)

Chapter 3    COVID 19 Impact Analysis

    3.1    Impact Assessment of COVID-19 Pandemic, By Region
        3.1.1    North America: Impact of COVID-19 Pandemic
        3.1.2    Europe: Impact of COVID-19 Pandemic
        3.1.3    Asia pacific: Impact of COVID-19 Pandemic
        3.1.4    Latin America: Impact of COVID-19 Pandemic
        3.1.5    Middle-East and Africa: Impact of COVID-19 Pandemic
    3.2    Key Strategies Undertaken by Companies to Tackle COVID-19
    3.3    Quarterly Market Revenue by Region 2021 & 2022
    3.4    Pre COVID-19 Market Revenue, By Region, 2016-2019        (USD Million)
    3.5    Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    3.6    Short Term Dynamics
    3.7    Long Term Dynamics

Chapter 4    Global Clinical Trials Matching Software Market, By Component Type Segment Analysis

    4.1    Clinical Trials Matching Software Market Overview, By Component Type Segment
        4.1.1    Global Clinical Trials Matching Software Market Revenue Share, By Component Type, 2022 & 2028 (Value, %)
    4.2    Services
        4.2.1    Clinical Trials Matching Software Share Forecast, By Region (USD Million)
        4.2.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        4.2.3    Key Market Trends, Growth Factors, & Opportunities
    4.3    Software
        4.3.1    Clinical Trials Matching Software Share Forecast, By Region (USD Million)
        4.3.2    Comparative Revenue Analysis, By Country, 2021 & 2028
        4.3.3    Key Market Trends, Growth Factors, & Opportunities
            
Chapter 5    Global Clinical Trials Matching Software Market, By End User Segment Analysis

    5.1    Clinical Trials Matching Software Market Overview, By End User Segment
        5.1.1    Global Clinical Trials Matching Software Market Revenue Share, By End User, 2022 & 2028 (Value, %)
    5.2    Clinical Research Organizations (CRO)
        5.2.1    Clinical Trials Matching Software Share Forecast, By Region (USD Million)
        5.2.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        5.2.3    Key Market Trends, Growth Factors, & Opportunities
    5.3    Pharmaceutical and biotechnology Companies
        5.3.1    Clinical Trials Matching Software Share Forecast, By Region (USD Million)
        5.3.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        5.3.3    Key Market Trends, Growth Factors, & Opportunities
    5.4    Medical Device Firms
        5.4.1    Clinical Trials Matching Software Share Forecast, By Region (USD Million)
        5.4.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        5.4.3    Key Market Trends, Growth Factors, & Opportunities
            
Chapter 6    Global Clinical Trials Matching Software Market, By Deployement Mode Segment Analysis

    6.1    Clinical Trials Matching Software Market Overview, By Deployement Mode Segment
        6.1.1    Global Clinical Trials Matching Software Market Value Share, By Deployement Mode, 2021 & 2028 (Value, %)
    6.2    On-Premise
        6.2.1    Clinical Trials Matching Software Share Forecast, By Region (USD Million)
        6.2.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        6.2.3    Key Market Trends, Growth Factors, & Opportunities
    6.3    Web and Cloud based
        6.3.1    Clinical Trials Matching Software Share Forecast, By Region (USD Million)
        6.3.2    Comparative Revenue Analysis, By Country, 2022 & 2028
        6.3.3    Key Market Trends, Growth Factors, & Opportunities
            
Chapter 7    Clinical Trials Matching Software Market – Regional Analysis, 2022 – 2028

    7.1    Clinical Trials Matching Software market Overview, by Region Segment
        7.1.1    Global Clinical Trials Matching Software market Revenue Share, By Region, 2022 & 2028
        7.1.2    Global Clinical Trials Matching Software Market Revenue, By Region, 2017 – 2028 (US$ Mn)
        7.1.3    Global Clinical Trials Matching Software market Revenue, By Component Type, 2017 – 2028 (US$ Mn)
        7.1.4    Global Clinical Trials Matching Software market Revenue, By End User, 2017 – 2028 (US$ Mn)
        7.1.5    Global Clinical Trials Matching Software Market Revenue, By Deployement Mode, 2017 – 2028 (US$ Mn)
    7.2    North America
        7.2.1    North America Clinical Trials Matching Software Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        7.2.2    North America Clinical Trials Matching Software Market Revenue, By Component Type, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.2.3    North America Clinical Trials Matching Software Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.2.4    North America Clinical Trials Matching Software Market Revenue, By Deployement Mode, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.2.5    U.S. Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.2.6    Canada Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.2.7    Mexico Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    7.3    Europe
        7.3.1    Europe Clinical Trials Matching Software Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        7.3.2    Europe Clinical Trials Matching Software Market Revenue, By Component Type, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.3.3    Europe Clinical Trials Matching Software Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.3.4    Europe Clinical Trials Matching Software Market Revenue, By Deployement Mode, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.3.5    Germany Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.3.6    France Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.3.7    U.K. Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.3.8    Italy Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.3.9    Spain Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.3.10    Rest of Europe Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    7.4    Asia Pacific
        7.4.1    Asia Pacific Clinical Trials Matching Software Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        7.4.2    Asia Pacific Clinical Trials Matching Software Market Revenue, By Component Type, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.4.3    Asia Pacific Clinical Trials Matching Software Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.4.4    Asia Pacific Clinical Trials Matching Software Market Revenue, By Deployement Mode, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.4.5    China Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.4.6    Japan Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.4.7    India Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.4.8    South Korea Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.4.9    South-East Asia Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.4.10    Rest of Asia Pacific Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    7.5    Latin America
        7.5.1    Latin America Clinical Trials Matching Software Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        7.5.2    Latin America Clinical Trials Matching Software Market Revenue, By Component Type, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.5.3    Latin America Clinical Trials Matching Software Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.5.4    Latin America Clinical Trials Matching Software Market Revenue, By Deployement Mode, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.5.5    Brazil Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.5.6    Argentina Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.5.7    Rest of Latin America Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
    7.6    The Middle-East and Africa
        7.6.1    The Middle-East and Africa Clinical Trials Matching Software Market Revenue, By Country, 2018 – 2028 (US$ Mn)
        7.6.2    The Middle-East and Africa Clinical Trials Matching Software Market Revenue, By Component Type, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.6.3    The Middle-East and Africa Clinical Trials Matching Software Market Revenue, By End User, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.6.4    The Middle-East and Africa Clinical Trials Matching Software Market Revenue, By Deployement Mode, 2018 – 2028 (US$ Mn)/(Kilo Tons)
        7.6.5    GCC Countries Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.6.6    South Africa Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)
        7.6.7    Rest of Middle-East Africa Clinical Trials Matching Software Market Revenue, 2018 - 2028 (US$ Mn)/ (Kilo Tons)

Chapter 8    Clinical Trials Matching Software Market – Industry Analysis

    8.1    Introduction
    8.2    Market Drivers
        8.2.1    Driving Factor 1 Analysis
        8.2.2    Driving Factor 2 Analysis
    8.3    Market Restraints
        8.3.1    Restraining Factor Analysis
    8.4    Market Opportunities
        8.4.1    Market Opportunity Analysis
    8.5    Porter’s Five Forces Analysis
    8.6    PEST Analysis
    8.7    Regulatory Landscape
    8.8    Technology Landscape
    8.9    Value Chain Analysis

Chapter 9    Competitive Landscape

    9.1    Company Market Share Analysis – 2022
        9.1.1    Global Clinical Trials Matching Software market: Company Market Share, 2022
        9.1.2    Global Clinical Trials Matching Software Market: Company Market Share, 2022
    9.2    Strategic Developments
        9.2.1    Acquisitions & Mergers
        9.2.2    New Product Launch
        9.2.3    Regional Expansion
    9.3    Company Strategic Developments – Heat Map Analysis

Chapter 10    Company Profiles

    10.1    Advarra
        10.1.1    Company Overview
        10.1.2    Key Executives
        10.1.3    Product Portfolio
        10.1.4    Financial Overview
        10.1.5    Operating Business Segments
        10.1.6    Business Segment Performance
        10.1.7    Recent Developments
    10.2    Antidote Technologies, Inc.
    10.3    IBM Clinical Development
    10.4    Clinical Trials Mobile Application
    10.5    SSS International Clinical Research
    10.6    Aris Global
    10.7    Clario
    10.8    Bsi Business Systems Integration AG
    10.9    Microsoft Corporation
    10.10    Ofni Systems

Chapter 11    Research Methodology

    11.1    Research Methodology
    11.2    Phase I – Secondary Research
    11.3    Phase II - Data Modeling
        11.3.1    Company Share Analysis Model
        11.3.2    Revenue Based Modeling
    11.4    Phase III – Primary Research
    11.5    Research Limitations
        11.5.1    Assumptions
No Methodology
No Available